amoxicillin/clavulanate potassium 1gm
Drugamoxicillin/clavulanate potassium 1gm
NCT Number: NCT00343135
Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections
Looking for future studies?
Notify Me12 year and older
All sexes
Interventional
Phase 4
GSK Investigational Site, Karachi, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
amoxicillin/clavulanate potassium 1gm
Time frame: 10 - 14 days
Time frame: 2 - 4 days
GlaxoSmithKline
Industry
An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03643952
Bacteremia, Bacterial Infections
Nagoya, Aichi-ken, Japan
View Trial DetailsNCT00761215
Bacterial Infections, Bacterial Infections and Mycoses
Dothan, Alabama, United States
View Trial DetailsNCT02600871
Abscess, Infections
San Antonio, Texas, United States
View Trial DetailsNCT01967225
Bacteremia, Bacterial Infections
Nagakute, Aichi-ken, Japan
View Trial Details